Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Oncogenic KRAS alters splicing factor phosphorylation and alternative splicing in lung cancer

Fig. 2

Oncogenic KRAS regulates alternative splicing in lung epithelial cell. A Schematic of the inclusion or skipping events of a cassette exon. B Differentially spliced exons in KRASG12V and KRASQ61H cells compared to KRASWT cells. PSI = Percent Spliced In. Red = exons promoted at least 10% more in KRASWT than KRASmut. Blue = exons promoted at least 10% more in KRASmut than KRASWT. FDR < 0.05. C Overlap of differentially spliced exons in KRASG12V vs KRASWT and KRASQ61H vs KRASWT. P-value calculated by modeling skipped exon events as a hypergeometric distribution. D Read coverage plots of skipped exon events in MOK and NT5C2, normalized by total RNA-seq library size and RNA composition. Left axis = percent coverage relative to region. Right axis = absolute read coverage

Back to article page